Aline Ecarnot-Laubriet
Overview
Explore the profile of Aline Ecarnot-Laubriet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oudot A, Vergely C, Ecarnot-Laubriet A, Rochette L
Regul Pept
. 2005 Feb;
127(1-3):101-10.
PMID: 15680476
The cardiovascular role of angiotensin-(1-7), especially in the functional and metabolic alterations associated with ischemia-reperfusion (IR), is still not clearly defined. Our objective was to evaluate the cardiac effects of...
2.
Vergely C, Goirand F, Ecarnot-Laubriet A, Renard C, Moreau D, Guilland J, et al.
J Nutr
. 2004 Mar;
134(4):729-35.
PMID: 15051818
Vitamin C is considered to be a very efficient water-soluble antioxidant, for which several new cardiovascular properties were recently described. The aim of this study was to determine in vivo...
3.
Ecarnot-Laubriet A, Rochette L, Vergely C, Sicard P, Teyssier J
Heart Dis
. 2003 Sep;
5(5):308-12.
PMID: 14503927
In the left ventricle subjected to pressure overload activity, the antioxidant enzymes increased at the hyperfunctional stage. During the transition to heart failure, these enzymes are down-regulated, oxidative stress increases,...
4.
Oudot A, Vergely C, Ecarnot-Laubriet A, Rochette L
Eur J Pharmacol
. 2003 Feb;
462(1-3):145-54.
PMID: 12591107
The role of angiotensin II in myocardial ischaemia-reperfusion is not clearly defined. In this respect, the involvement of NADPH oxidase remains to be determined. The aim of this study was...